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Introduction
Hearing loss (HL) is a common sensorineural disorder, 
with an incidence of 1 in every 500-1,000 children [1]. At 
least half of the HL cases can be attributed to genetic factors 
and more than two-third of these individuals are classified as 
autosomal recessive non-syndromic hearing loss (ARNSHL) 
[2]. Non-syndromic or syndromic HL may be caused by en-
vironmental factors in configuration with a certain genotype. 
But it should be noted that the environmental factors are al-
most ineffective on the gap junction protein beta 2 (GJB2) 
gene. Because HL is extremely heterogeneous, studying large-
sized families from different ethnicities such as the Middle 
East populations are helpful [3].
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Background and Objectives: Autosomal recessive non-syndromic hearing loss (ARNSHL) 
with genetic origin is common (1/2000 births). ARNSHL can be associated with mutations in 
gap junction protein beta 2 (GJB2). To this end, this cohort investigation aimed to find the 
contribution of GJB2 gene mutations with the genotype-phenotype correlations in 45 ARN-
SHL cases in the Kurdish population. Subjects and Methods: Genomic DNA was extracted
from a total of 45 ARNSHL families. The linkage analysis with 3 short tandem repeat mark-
ers linked to GJB2 was performed on 45 ARNSHL families. Only 9 of these families were 
linked to the DFNB1 locus. All the 45 families who took part were sequenced for confirma-
tion linkage analysis (to perform a large project). Results: A total of three different mutations 
were determined. Two of which [c.35delG and c.-23+1G>A (IVS1+1G>A)] were previously 
reported but (c.299-300delAT) mutation was novel in the Kurdish population. The homo-
zygous pathogenic mutations of GJB2 gene was observed in nine out of the 45 families 
(20%), also heterozygous genotype (c.35delG/N)+(c.-23+1G>A/c.-23+1G>A) were ob-
served in 4/45 families (8.8%). The degree of hearing loss (HL) in patients with other muta-
tions was less severe than patients with c.35delG homozygous mutation (p<0.001). Conclu-
sions: Our data suggest that GJB2 mutations constitute 20% of the etiology of ARNSHL in 
Iran; moreover, the c.35delG mutation is the most common HL cause in the Kurdish popu-
lation. Therefore, these mutations should be included in the molecular testing of HL in this 
population. J Audiol Otol 2019;23(1):20-26
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At least 42 genetic loci are associated with syndromic forms 
and over 163 genetic loci are associated with non-syndromic 
HL (http://hereditaryhearingloss.org/). The inheritance of the 
disease may be autosomal recessive, autosomal dominant, X-
linked recessive and mitochondrial [4]. Based on different in-
vestigations, mutations of GJB2 gene are the most common 
cause of ARNSHL worldwide (e.g. Iran).
The connexin 26 (Cx26) gap junctional proteins are encod-
ed by GJB2 gene. Gap junctions are clusters of intercellular 
channels for cell-to-cell diffusion of small molecules [5]. 
These proteins exist in different organs and tissues. For exam-
ple, the second messenger inositol 1,4,5-trisphosphate (IP3) 
are in cochlea which transmit signals to intracellular compart-
ments and are essential in perceiving sounds, originally as-
signed to chromosome 13q12. It accounts for about 50% of 
this common type of HL [6].
The c.35delG mutation that has been tested in recombinant 
expression systems confirmed loss of function due to altered 
sorting, also this mutation, is the most frequent recessive Cx26 
mutation in Caucasoid families, which results in a frameshift 
and premature termination of the protein. The pattern of GJB2 
allele distribution has a considerable diversity among different 
races and ethnic groups. A variant-specific, the c.35delG muta-
tion, accounts for >70% of the disease alleles in the northern 
and southern Europe as well as American Caucasian, carrier 
frequencies range from 1.3% to 2.8% [7]. 
However, the high spectrum and prevalence of GJB2 mu-
tations in exon 2 (coding) exists but the prevalence of this 
mutations are also significantly evident in exon 1 (non-cod-
ing) [8]. The c.-23+1G>A and c.299-300delAT mutations 
were already detected respectively in exon 1 and exon 2 of 
GJB2, the c.-23+1G>A is a splice site mutation [9], and the 
c.299-300delAT mutation was reported to be the severe phe-
notype of ARNSHL in this population.
The c.299-300delAT mutation caused that gap junction 
proteins cannot form in the plasma membrane. These dis-
abled proteins were remained in the endoplasmic reticulum 
(ER), it proposed that ER stress (ERS) and followed of ERS-
induced cell death may be responsible for HL [10].
The c.299-300delAT mutation is a frameshift that caused 
an altered amino acid sequence. Studies showed that c.-23+ 
1G>A produced non-functional mRNA [11]. The c.-23+1G 
>A mutation was shown in different frequencies between var-
ious populations including Mongolian, Yakut, Czech, Hun-
garian, Turkish and Iranian. However, they do not provide a 
sufficient data on the frequency of GJB2 mutations with gen-
otype-phenotype correlation, in certain ethnic groups such as 
Kurds [12]. This study focuses on assessing the contribution 
of GJB2 mutations (exons 1 and 2) for developing an early 
onset of HL. Moreover, it aims to determine the mutation pro-
file with genotype-phenotype correlation in hearing-impaired 
Kurdish participants.
Subjects and Methods
Subjects
In this study 45 Kurdish families with the ARNSHL were 
selected from a genetic counseling clinic in Iran. ARNSHL in-
dividuals were selected by screening the family pedigrees, the 
patients’ audiograms, the medical records, and also the indi-
vidual information of each patient in these families. They were, 
therefore, 45 non-related families. All the family members 
were interviewed after signing a written consent form. The cri-
teria for choosing individuals to take part in the study were as 
follows: 1) Autosomal recessive pattern of inheritance should 
be suspected; 2) Clinical and demographic information should 
be provided; 3) There must be no syndromic (signs and symp-
toms other than HL) or environmental evidence (infections 
such as rubella, meningitis, and ototoxic drugs); and 4) At 
least two patients should exist in the family. 
The Review Board of Shahrekord University of Medical 
Sciences, Shahrekord, Iran, confirmed this study in 2016 (IR.
SKUMS.REC.1395.105). After filling out an informed consent 
form, about 5 mL of peripheral blood was collected in tubes 
containing EDTA (0.5 M) from all ARNSHL family members. 
Also in this study, we collected samples of three generations in 
each family (grandparents and cousins were included).
DNA extraction
DNA was extracted using a DNA extraction kit (DNPTM, 
CinnaGen, Tehran, Iran). The quality and quantity of DNA 
samples can be checked with the Nanodrop spectrophotometer 
(Thermo Scientific NanoDrop 1000 Spetrophotometer, Ther-
mo Scienific, Wilmington, NC, USA).
Genetic analysis of GJB2
Two methods of mutation detection including genetic link-
age analysis followed by DNA sequencing of GJB2 were used. 
Altogether 45 families participated in parallel in this study.
Amplification of the short tandem repeat markers by 
linkage analysis
PCR reaction of three primer pairs for three DFNB1 short 
tandem repeat (STR) markers was performed (Table 1). The 
amplified conditions were as follows: reaction volume was 
15 μL with a final concentration of: ddH2O 7.5 μL, master 
mix 5.5 μL, Primer F 0.5 μL (20 pmol/μL), Primer R 0.5 μL 
(20 pmol/μL), and template genomic DNA 1 μL (100 ng/μL).
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The PCR-reactions were performed in a thermal cycler 
(Program Temp Control System PC-700, ASTEC, Fukuoka, 
Japan) with the following conditions: 95°C for 3 minutes, 30 
cycles including 95°C for 30 seconds, 57°C for 30 seconds, 
72°C for 30 seconds, and finally 72°C for 6 minutes. PCR am-
plicons were analyzed on a 15% polyacrylamide gel electro-
phoresis [13] (Fig. 1). Haplotype and LOD score analysis were 
used to infer genetic linkage to DFNB1 as previously described 
(Fig. 1).
The 9 families linked to DFNB1 locus were further ana-
lyzed for mutation detection but GJB2 was sequenced in 
each of the tests performed on 45 families to confirm linkage 
analysis (to carry out a large project and to investigate other 
effective genes in HL by linkage analysis). The mutations 
were detected in the 9 families linked and so our results con-
firm the accuracy of linkage analysis. 
Mutation analysis of GJB2 gene in patients by sequence 
analysis
The GJB2 gene sequencing was performed on one patient 
in each of the families. Genomic DNA was PCR amplified for 
sequencing using the following primer pairs: F2: 5' CTC CCT 
GTT CTG TCC TAG CT 3', R2: 5' CTC ATC CCT CTC ATG 
CTG TC 3' covering the exon 2 of GJB2. To amplify the exon 
1 of GJB2 gene, the following primers were used: F1: 5' CGT 
CTT TGG GGG TGT TGC TT 3', R1: 5' CAT GAA GAG 
GGC GTA CAA GTT AGA A 3'.
The amplification conditions were as follows: reaction vol-
ume was 25 μL with a ﬁnal concentration of: ddH2O 18 μL, 
MgCl2 1.7 μL (100 mM), dNTPs 0.5 μL (10 mM), PCR buf-
fer 2.5 μL, Taq polymers 0.3 μL (3 units/μL), primer F 0.5 μL 
(20 pmol/μL), primer R 0.5 μL (20 pmol/μL), and template 
genomic DNA 1 μL (100 ng/μL). The PCR-reaction was per-
formed in a thermal cycler (Program Temp Control System 
PC-700, ASTEC) at 95°C for 4 minutes, 35 cycles including 
95°C for 30 seconds, 60°C for 30 seconds, 72°C for 24 seconds, 
and finally 72°C for 5 minutes. Sequencing was carried out in 
SEQLAB (Sequence Laboratories, Gottingen, Germany).
The audiological study of GJB2 mutation positive patients
For each patient (3 to 35 years old), a complete database of 
the patient’s medical conditions was reviewed to understand 
the cause of HL, no environmental factors such as maternal 
to fetal infections, prenatal complications, bacterial or viral 
infection (meningitis), prenatal and postnatal ototoxic drugs 
such as aminoglycosides were involved in HL. All the af-
fected family members underwent an ear examination and a 
general health check to determine the type of HL. 
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Fig. 1. Haplotype analysis of the Iran-
Saberi pedigree was shown in up 
figure and being linked to the D13S 
1236 marker of GJB2 gene was de-
tected by the 15% polyacrylamide 
gel at this pedigree in down figure. 
Healthy individuals were heterozy-
gous (1/2); three patients were ho-
mozygous (1/1).
Table 1. The short tandem repeat markers of DFNB1 (GJB2) and their primer sequences
Primer name Type of primer Primer sequence (5’ → 3’) Fragment size (bp)
D13S1236 Primer R
Primer F
AAGGGGCTGGCTCTTCA
GCACTTGGCCTGGGTAA
108-132
D13S1275 Primer R
Primer F
CCAGCATGACCTTTACCAG
ATCACTTGAATAAGAAGCCATTTG
180-214
D13S175 Primer R
Primer F
TGCATCACCTCACATAGGTTA
TATTGGATACTTGAATCTGCTG
101-113
F: Forward, R: Reverse
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Individuals were also screened for vision assessment, pro-
teinuria, and haematuria. Hearing sensitivity was measured 
by pure-tone audiometric test (PTA) for air and bone conduc-
tion at different frequencies (250-8,000 Hz) in all patients. 
The degree of HL was classified according to the PTA aver-
age at 500, 1,000, 2,000 and 4,000 Hz: mild ≥21 dB, moder-
ate ≥46 dB, moderately severe ≥61 dB, severe ≥76 dB and 
profound ≥97 dB [14]. 
Statistical analysis
The data was analyzed by SPSS 11.5 (SPSS Institute, Chi-
cago, IL, USA). The χ2 or Fisher’s exact tests was used to 
detect differences in Genotype-phenotype with GJB2 muta-
tions. A p value <0.05 was accepted as statistically significant.
Results
In this research 45 Kurdish families were selected to deter-
mine the genetic and molecular basis of hearing impairment. 
HL state was autosomal recessive in this research. HL occur-
rences may vary in range from mild to profound. Linkage anal-
ysis was performed with 3 STR markers (Table 1). Linkage 
analysis and sequencing were performed for all 45 families 
who participated in the study but only 9 families were linked 
to the locus DFNB1 and their mutations were detected by se-
quencing analysis. So our results confirm the accuracy of link-
age analysis.
The c.35delG mutation was detected in 17.7% (8/45) of 
Kurdish population and the allele frequency was 13.33% (12 
positives in 90 alleles). In the 45 families analyzed, the homo-
zygous state was observed for this mutation in 8.8% of the 
Kurdish population, the heterozygous state was observed in 
8.8% and 82.4% of these individual have no c.35delG mutation.
Furthermore, in the next step of the study all individuals 
who were not c.35delG positive and 4 heterozygous patients 
for this mutation were analyzed to detect other mutations in 
the entire coding and exon 1 (noncoding) of GJB2 gene us-
ing direct genomic DNA sequencing (Fig. 2). In 8.8% (4/45) 
of the families, homozygosity for the c.23+1G>A mutation 
was found in exon 1, also these 4 families had heterozygosity 
for the c.35delG mutation (Table 2). In addition, 2.2% (1/45) 
of the families had homozygosity for the c.299-300delAT 
mutation in exon 2 (Fig. 2). This is the first reported mutation 
in Kurdish population.
 
Genotype-phenotype correlation of GJB2 patients
Patients with (c.35delG/N)+(c.-23+1G>A/c.-23+1G>A) 
genotype and c.35delG homozygous genotype were investi-
gated audiologically. This analysis was carried out on 19 pa-
tients from 8 families with GJB2 mutations. Ten patients from 
these families with profound HL (≥97 dB) at 500, 1,000, 2,000 
and 4,000 Hz had c.35delG homozygous mutation (4 fami-
Fig. 2. The electropherograms of the GJB2 sequance normal 
form (A), the c.35delG homozygous mutation (B), the c.35delG 
heterozygous mutation (C), the GJB2 sequance normal form (D), 
the c.23+1G>A homozygous mutation (E), the GJB2 sequance 
normal form (F) and the c.299-300delAT homozygous mutation 
(G), genotypes are shown. Arrows show the location of the base 
change.
Normal
Normal
c.23+1G>A homozygous
c.299-300delAT
Normal
c.35delG homozygous
c.35delG heterozygous
deletion G
A
B
C
D
E
F
G
deletion G
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lies), and 9 other patients (4 families) with moderately severe 
HL (=61 dB) (Fig. 3) had (c.35delG/N)+(c.-23+1G>A/c.-23+ 
1G>A) genotype (p<0.001) (Fig. 4). Fisher’s exact test was 
used to detect a positive genotype-phenotype correlation in 
two genotypes (Table 3). A patient with severe phenotype (≥76 
dB) had the c.299-300delAT homozygous genotype.
Discussion
In the present research, the contribution of GJB2 muta-
tions was associated to the HL in nine out of the 45 ARN-
SHL Kurdish families. We developed a simple, accurate meth-
od to determine the c.35delG mutation. Three GJB2 mutations 
were determined in the present research. The c.35delG muta-
tion, c.-23+1G>A mutation, and c.299-300delAT mutation 
(first report in Kurdish population) have already been inves-
Fig. 3. Pure tone audiometries of profound and moderately severe with two GJB2 mutations [c.35delG homozygous and (c.35delG/N)+(c.-
23+1G>A/c.-23+1G>A) genotype] respectively are in patient 2 and patient 1.
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Fig. 4. Distribution of two classes of HL: the c.35delG homozy-
gous and the (c.35delG/N)+(c.-23+1G>A/c.-23+1G>A) genotype 
(p<0.001).
Table 2. Details of GJB2 gene mutations investigated in mutation taster
Site
Clinical 
significance 
Exon
Nucleotide 
change
Variant 
type
Protein change
Patients
homozygous
Patients
heterozygous
Origin
Mutation taster Pathogenic 2 c.35delG 
(rs80338939)
Deletion frameshift 4 (8.8%) 4 (8.8%) Germ line
Mutation taster Pathogenic 1 c.23+1G>A 
(rs80338940)
Splice site Non-coding 4 (8.8%) - Germ line
Mutation taster Pathogenic 2 c.299-300delAT 
(rs111033204)
Deletion Frameshift 
(leading to a stop 
at Codon)
1 (2.2%) - Germ line
Table 3. Comparison of our data and the literature for specific 
GJB2 genotype-phenotype correlations
 Mutation and 
genotype
No. of 
subjects
Frequency 
of moderately 
severe
Frequency 
of 
profound
p
value*
c.35delG/c.35delG 10 (52.6) 0 (0) 10 (100)
<0.001
(c.35delG/N)+
(c.-23+1G>A/
c.-23+1G>A)
9 (47.4)
 
9 (100)
 
0 (0)
 
Values are presented as numbers (%). *p value calculated by 
comparing two genotypes to hearing sensitivity, Fisher’s exact 
tests were used to determine genotype-phenotype positive 
correlation in this study
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tigated [11]. GJB2 mutations were detected in 9 ARNSHL 
(20%) patients which was similar to the results of the previous 
investigations in other regions of Iran [4,15].
The severity of the HL in these 9 patients varied from mod-
erately severe to profound. This study determined the correla-
tion between the phenotype and the GJB2 mutations. Patients 
with c.35delG/N mutation may have a homozygous different 
pathogenic mutation in other places. Then after sequencing of 
the entire coding and noncoding sequence of GJB2 gene, ho-
mozygous c.299-300delAT (2.2%) and c.-23+1G>A (8.8%) 
mutations were observed. Based on these findings, the ARN-
SHL phenotype in families with c.35delG heterozygote state 
associated to c.-23+1G>A homozygous state was moderately 
severe, while families with homozygous c.35delG (8.8%) mu-
tation had profound HL.
Our results detected the contribution of common GJB2 
mutations in Kurdish population. Various investigations had 
determined that the c.35delG mutation is the most common in 
many ethnic groups, this mutation accounts for 85% of the mu-
tations in GJB2 gene [6]. It is probable that the c.35delG mu-
tation originated in ancient Greece and was subsequently prop-
agated in the Mediterranean [16]. The c.35delG is the most 
common mutation in the Mediterranean [17], which shows 
genetic heterogeneity of HL.
The frequency of the c.35delG mutation in the Oman deaf 
population is null [18], as in African Americans [19], Ghana-
ian [20], and Kenyan populations [21]. The frequency of this 
mutation is less than 4% in Australia [22] and Sudan (2.7%); 
in Iran it is similar to other Mediterranean populations. Also, 
the main mutations in the GJB2 gene in Dagestan were rep-
resented by three forms typical for West Asia: c.35delG mu-
tation (22% of all mutant alleles), deltaE120 mutation (22%), 
and c.-23+1G>A (44%) were found in a compound hetero-
zygous or a heterozygous state [23], and in Çukurova region 
of turkey the c.35delG mutation was known as the most fre-
quent mutation of GJB2 gene and had the most frequently 
mutation (5.5%) in patients with HL [24].
Variation in frequency between different ethnic groups can 
be the result of human migrations; the high prevalence of the 
c.35delG mutation in Caucasian populations is possibly the re-
sult of a founder effect rather than a mutational hot spot [25]. 
The Iranian population is composed of various ethnic groups; 
the prevalence of this mutation differs between Iranian popula-
tion with a higher slope of mutation frequency from south-tonorth 
(0% to 33%), and from east-to-west (8% to 8.8%) [12,15].
As a result, GJB2 gene related HL has a low portion of 
ARNSHL in our population comparing to other ones [26]. The 
high percentage in northwest and center of Iran may be due 
to immigration of people in some cities in Iran or may be due 
to the consanguinity or ascertainment among different ethnic 
groups. The observations support the presence of a founder 
effect in northern Iran (compared to 43% in Anatolia) [19]. 
Based on the population frequencies of the c.35delG mutation 
and tribes migrating from central Asia to Anatolia 10 centu-
ries ago, we think that the c.35delG mutation probably arose 
in northwest of Iran [19]. 
The c.-23+1G>A and c.299-300delAT mutations are among 
the top ten GJB2 mutations responsible for HL within various 
populations [14]. Functional studies of c.-23+1G>A muta-
tion have not obtained detectable GJB2 protein and mRNA 
[11]. Homozygous c.-23+1G>A mutation reported in Iran’s 
ethnic groups have a different percentage (2.5% average), in 
another study [27], which is lower than our observation (8.8%).
The (c.35delG/N)+(c.-23+1G>A/c.-23+1G>A) genotype 
was less severe than that of c.35delG homozygous (p<0.001). 
We conclude that c.-23+1G>A homozygous mutation is of-
ten restricted in the Kurdish population; that shows a founder 
effect for this mutation. Also, we could identify c.299-300de-
lAT homozygous mutation in one Kurdish family for the first 
time in Iran who had severe phenotype ARNSHL. The c.299-
300delAT mutation is a frameshift that caused an altered ami-
no acid sequence from codon 100, leading to a stop at codon 
113 (Fig. 5).
This mutation was first reported as a heterozygote variant 
related to ARNSHL [28]. Another study found this mutation 
in homozygote form [29], and then reported it in Turkey [30], 
and Iran [12]. These findings suggested the involvement of 
other genetic or environmental causes playing an important 
role in manifesting any disorders in this population. So far, eti-
ology of this disorder remains largely unknown; the presence of 
modifier gene or other connexin genes can be involved in HL. 
Consequently, more investigations should be conducted to 
search the existence of pathogenic mutations in other loci. The 
high penetrance of GJB2 mutations (very much the c.35delG 
and c.-23+1G>A) in Kurdish population may increase the 
chance for determining newborns with the ARNSHL by ge-
netic testing. So, it can prevent unnecessary diagnostic testing 
and improve its diagnosis and treatment in Iran. The Iranian 
c.35delG
NH2
COOH
1 2 3 4
c.299-300delAT
Fig. 5. The location of the GJB2 mutations in the connexion protein.
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population is composed of various ethnic groups.
Therefore, further studies on the basis of the ethnicity are 
necessary to identify the ethnicity-based gene profile associ-
ated with ARNSHL. So these observations can be helpful in 
clinical settings to prognosticate the outcomes of genetic test-
ing and disease period to the individuals with HL in Kurdish 
population.
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